id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2025-N-1264-0001,FDA,FDA-2025-N-1264,Medical Devices; Hematology and Pathology Devices; Classification of the Fluorescence In Situ Hybridization-Based Detection of Chromosomal Abnormalities From Patients With Hematologic Malignancies,Rule,Final Rule,2025-06-26T04:00:00Z,2025,6,2025-06-26T04:00:00Z,,2025-06-26T17:27:00Z,2025-11793,0,0,09000064b8e322d7